Pharmacoproteomics stands at the forefront of pharmaceutical research, delving into the intricate web of proteins expressed within cells, tissues, or organisms in response to pharmaceutical interventions. This multidisciplinary domain seamlessly integrates pharmacological principles with cutting-edge proteomic methodologies, utilizing sophisticated techniques like mass spectrometry and bioinformatics. The primary objective is to decipher the intricate interplay between pharmaceutical agents and the proteome. By leveraging advanced technologies, pharmacoproteomics endeavors to meticulously identify, quantify, and characterize alterations in protein expression and post-translational modifications induced by drug treatments. This holistic approach provides a nuanced understanding of the molecular mechanisms governing drug actions, shedding light on potential side effects and elucidating individual variations in drug responses. Despite its immense potential, pharmacoproteomics encounters challenges that demand attention within the pharmaceutical landscape. Issues such as data integration and standardization persist, necessitating continual efforts to augment the reproducibility and reliability of pharmacoproteomic studies.
Submit your abstract Today
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India